Pneumonia Testing Market Outlook:
Pneumonia Testing Market size was USD 2.5 billion in 2025 and is anticipated to reach USD 4.6 billion by the end of 2035, increasing at a CAGR of 7.2% during the forecast period, i.e., 2026-2035. In 2026, the industry size of pneumonia testing is assessed at USD 2.6 billion.
Globally, the market is witnessing growth, majorly due to a surge in pneumonia incidence. According to the 2025 World Health Organization (WHO) report, pneumonia has readily affected more than 808,000 children within the age of 5 years, which accounted for 15% of overall deaths globally. In addition, adults more than 65 years of age are also at risk for pneumonia, which is also driving the market’s demand. Besides, the overall market’s growth is also driven by other interconnected factors, including an increase in awareness for early diagnosis, a surge in governmental strategies, the presence of accurate and rapid testing methods, and advancements in diagnostic technologies.
Moreover, chest x-ray as a diagnostic tool is readily sourced across nations through import and export facilities, which is positively impacting the market. According to the 2023 OEC report, the global export valuation of this tool is USD 9.3 million, and the import valuation is USD 123 million. In addition, India’s share in global exports is 0.1%, and it is ranked 21 out of 103, along with the global import share accounting for 2.4%, with a rank of 9 out of 181. Besides, as per the October 2023 NLM report, only 5% to 12% of adults suffering from pneumonia are diagnosed, with symptoms lower respiratory tract infection. Additionally, 22% to 42% are admitted to hospitals, with a mortality rate of 5% and 14%, thereby denoting an increase in the demand for the market.
